CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 100 filers reported holding CHEMOCENTRYX INC in Q1 2018. The put-call ratio across all filers is 1.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $930,000 | -87.4% | 100,000 | -81.1% | 0.22% | -88.7% |
| Q1 2019 | $7,364,000 | +298.7% | 530,175 | +213.2% | 1.99% | +195.4% |
| Q4 2018 | $1,847,000 | +272.4% | 169,257 | +102.9% | 0.67% | +140.4% |
| Q4 2017 | $496,000 | +165.2% | 83,428 | +231.3% | 0.28% | +188.7% |
| Q3 2017 | $187,000 | -91.8% | 25,182 | -89.7% | 0.10% | -91.1% |
| Q2 2017 | $2,292,000 | +7.1% | 244,850 | -16.8% | 1.09% | -9.1% |
| Q1 2017 | $2,141,000 | -11.1% | 294,150 | -9.6% | 1.20% | -14.7% |
| Q4 2016 | $2,407,000 | -35.1% | 325,250 | -47.0% | 1.40% | -45.1% |
| Q3 2016 | $3,708,000 | +28.5% | 613,890 | -4.5% | 2.56% | +73.5% |
| Q2 2016 | $2,886,000 | – | 642,828 | – | 1.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |